| Quarterly Financials | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 53 | 56 | 60 | 64 | 54 | 57 | 59 | 68 | 62 | 68 | 70 | 78 | 89 | 107 | 132 | 156 | 123 | 127 | 121 | 150 | 133 |
| Expenses | 44 | 47 | 52 | 56 | 48 | 50 | 52 | 55 | 53 | 57 | 58 | 65 | 77 | 90 | 113 | 131 | 101 | 103 | 94 | 113 | 99 |
| EBITDA | 8 | 8 | 7 | 8 | 7 | 7 | 8 | 13 | 8 | 10 | 12 | 13 | 12 | 16 | 19 | 25 | 22 | 24 | 27 | 37 | 34 |
| Operating Profit % | 14 % | 11 % | 9 % | 3 % | 7 % | 8 % | 10 % | 10 % | 11 % | 10 % | 11 % | 13 % | 12 % | 12 % | 12 % | 12 % | 14 % | 15 % | 18 % | 16 % | 21 % |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 2 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 7 | 7 | 6 | 6 | 5 | 5 | 6 | 10 | 6 | 8 | 9 | 10 | 10 | 15 | 17 | 23 | 20 | 22 | 25 | 34 | 32 |
| Tax | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 6 | 5 | 5 | 6 | 9 | 7 |
| Net Profit | 5 | 6 | 4 | 5 | 4 | 4 | 4 | 9 | 4 | 7 | 7 | 7 | 8 | 11 | 13 | 18 | 16 | 17 | 19 | 25 | 25 |
| EPS in ₹ | 0.07 | 0.06 | 0.07 | 0.05 | 0.03 | 0.06 | 0.06 | 0.10 | 0.07 | 0.08 | 0.09 | 0.10 | 0.11 | 0.16 | 0.14 | 0.19 | 0.21 | 0.18 | 0.20 | 0.27 | 0.26 |
Syncom Formulations
Syncom Formulations
17.18
+1.04
(6.44%)
Market Cap
1,614.92 Cr
PE Ratio
17.74
Volume
1,66,22,375.00
Day High - Low
17.64 - 16.30
52W High-Low
18.70 - 10.21
Key Fundamentals
Market Cap
1,614.92 Cr
EPS
0.81
PE Ratio
17.74
PB Ratio
3.66
Book Value
4.41
EBITDA
77.43
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
14.45
Debt to Equity
0.12
Actual
Company News
View All News
Syncom Formulations Q1FY27 profit jumps 56% YoY
Aug 11, 2026
Aug 11, 2026Syncom Formulations (India) Ltd reported a 56% YoY rise in standalone net profit to ₹24.59 crore for Q1FY27, driven by growth in its pharmaceuticals segment. The company also restated EPS figures to comply with Ind AS 33.
Syncom Formulations approves Q1FY27 results and recommends a final dividend of ₹0.10 per share. The board also noted resignations of three senior executives and appointed replacements.
Syncom Formulations MD Vijay Bankda resignsAug 08, 2026
Aug 08, 2026Vijay Shankarlal Bankda steps down as Managing Director of Syncom Formulations (India) Ltd effective August 11, 2026, citing planned leadership transition and succession planning.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,910.00 | #1 4,58,272.98 | 37.64 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 45.69 | |
8,496.00 | 2,25,542.11 | 77.60 | 11,067.00 | 13.95 | 2,568 | 65.50 | 67.19 | |
4,886.50 | 1,85,866.75 | 86.11 | 13,886.20 | 20.34 | 2,138 | 3.28 | 48.05 | |
1,437.90 | 1,16,160.08 | 34.33 | 29,044.60 | 2.24 | 3,870 | -39.18 | 48.21 | |
1,103.80 | 1,11,068.11 | 24.33 | 27,657.90 | 17.64 | 5,026 | -34.90 | 44.37 | |
2,188.00 | 1,00,042.48 | #1 18.06 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 27.99 | |
1,190.00 | 99,325.62 | 30.81 | 35,058.60 | 3.90 | 4,158 | -69.10 | 48.40 | |
2,374.50 | 98,065.89 | 47.38 | 14,636.40 | 14.85 | 1,938 | 29.13 | 38.57 | |
1,801.00 | 97,228.17 | 89.92 | 6,867.80 | 22.01 | 890 | #1 123.93 | 59.80 | |
1,608.00 | 92,520.77 | 25.36 | 34,145.20 | 5.56 | 3,503 | 25.21 | 51.29 |
Growth Rate
Revenue Growth
1.40 %
Net Income Growth
58.40 %
Cash Flow Change
493.29 %
ROE
64.39 %
ROCE
45.46 %
EBITDA Margin (Avg.)
0.27 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 138 | 175 | 180 | 308 | 378 | 405 | 413 | 534 |
| Fixed Assets | 46 | 46 | 55 | 94 | 91 | 120 | 125 | 184 |
| Current Assets | 79 | 86 | 83 | 140 | 182 | 275 | 270 | 330 |
| Capital Work in Progress | 0 | 5 | 0 | 6 | 26 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 43 | 64 | 66 | 93 | 63 |
| Other Assets | 92 | 125 | 125 | 165 | 197 | 219 | 196 | 0 |
| Total Equity & Liabilities | 138 | 175 | 180 | 308 | 378 | 405 | 413 | 534 |
| Current Liabilities | 32 | 60 | 55 | 78 | 113 | 107 | 59 | 104 |
| Non Current Liabilities | 6 | 6 | 8 | 8 | 9 | 10 | 12 | 15 |
| Total Equity | 100 | 109 | 117 | 222 | 256 | 288 | 342 | 415 |
| Reserve & Surplus | 22 | 31 | 39 | 131 | 162 | 194 | 248 | 321 |
| Share Capital | 78 | 78 | 78 | 86 | 94 | 94 | 94 | 94 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 2 | -1 | 1 | -3 | 1 | 63 | -63 |
| Investing Activities | 1 | -23 | -18 | -27 | -45 | 83 | -18 |
| Operating Activities | 0 | 24 | 14 | 16 | 11 | -6 | 23 |
| Financing Activities | 1 | -2 | 5 | 8 | 35 | -15 | -68 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Nov 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 41.18 % | 41.18 % | 44.01 % | 44.01 % | 46.12 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % | 50.57 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.08 % | 0.09 % | 0.10 % | 0.13 % | 0.11 % | 0.41 % | 0.10 % | 0.26 % | 0.21 % | 0.35 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 54.31 % | 54.11 % | 51.35 % | 51.08 % | 49.68 % | 44.86 % | 44.91 % | 45.03 % | 45.02 % | 44.85 % | 45.00 % | 44.76 % | 44.82 % | 44.85 % | 45.08 % | 45.14 % | 45.06 % | 45.20 % | 44.83 % | 45.21 % | 45.04 % | 45.15 % | 44.90 % |
| Others | 4.51 % | 4.71 % | 4.64 % | 4.90 % | 4.19 % | 4.57 % | 4.52 % | 4.40 % | 4.41 % | 4.59 % | 4.43 % | 4.67 % | 4.61 % | 4.50 % | 4.27 % | 4.18 % | 4.24 % | 4.12 % | 4.19 % | 4.12 % | 4.13 % | 4.06 % | 4.18 % |
| No of Share Holders | 72,450 | 93,207 | 1,20,800 | 1,88,981 | 2,32,617 | 2,35,517 | 2,32,749 | 2,31,495 | 2,32,069 | 2,27,478 | 2,24,925 | 2,24,252 | 2,89,982 | 3,25,761 | 3,76,530 | 4,69,242 | 4,89,520 | 4,84,529 | 4,71,066 | 4,57,364 | 4,42,280 | 4,31,690 | 4,22,114 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 2.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.5 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2026 |  Annual General Meeting | NA | 30 Sept 2026 | 14.40 | 16.14 |
| 23 Sept 2026 |  Dividend | ₹ 0.10 /share | 23 Sept 2026 | 14.40 | 16.14 |
| 13 Sept 2022 | Dividend | ₹ 0.03 /share | 09 Sept 2022 | 9.18 | 9.18 |
| 26 Sept 2023 | Annual General Meeting | NA | 26 Sept 2023 | 9.14 | 8.50 |
| 30 Sept 2024 | Annual General Meeting | NA | 30 Sept 2024 | 23.19 | 21.98 |
| 11 Nov 2024 |  Quarterly Result Announcement | NA | 11 Nov 2024 | 20.83 | 20.52 |
| 10 Feb 2025 | Quarterly Result Announcement | NA | 10 Feb 2025 | 18.44 | 18.44 |
| 19 May 2025 | Quarterly Result Announcement | NA | 19 May 2025 | 16.44 | 17.51 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 18.01 | 17.88 |
| 29 Sept 2025 | Annual General Meeting | NA | 29 Sept 2025 | 18.27 | 16.71 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 16.10 | 16.01 |
| 12 Feb 2026 | Quarterly Result Announcement | NA | 12 Feb 2026 | 13.39 | 14.20 |
| 22 May 2026 | Quarterly Result Announcement | NA | 22 May 2026 | 13.60 | 14.27 |
| 11 Aug 2026 | Quarterly Result Announcement | NA | 11 Aug 2026 | 13.35 | 14.40 |
Announcements
Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015(Listing Regulations): Press ReleaseAug 13, 2026
Aug 13, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 12, 2026
Aug 12, 2026Announcement under Regulation 30 (LODR)-Change in ManagementAug 11, 2026
Aug 11, 2026Corporate Announcement/Information Pursuant To Regulation 44 Of The SEBI (LODR) Regulations 2015Aug 11, 2026
Aug 11, 2026Disclosure Pursuant To Regulation 30 Read With Schedule III Of The SEBI (LODR) Regulations 2015.Aug 11, 2026
Aug 11, 2026Regulation 33(3) Of SEBI (LODR) Regulations 2015- Submission Of The Un-Audited Standalone And Consolidated Financial Results Along With Limited Review Report Thereon For The Quarter Ended 30Th June 2026.Aug 11, 2026
Aug 11, 2026Corporate Action-Board approves DividendAug 11, 2026
Aug 11, 2026Board Meeting Outcome for Outcome Of The 2/2026-27 Meeting Of The Board Of Directors Of The Company.Aug 11, 2026
Aug 11, 2026Announcement under Regulation 30 (LODR)-Resignation of Managing DirectorAug 10, 2026
Aug 10, 2026Announcement under Regulation 30 (LODR)-Resignation of Managing DirectorAug 08, 2026
Aug 08, 2026Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Aug 08, 2026
Aug 08, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorAug 08, 2026
Aug 08, 2026Corporate Action-Board to consider DividendAug 06, 2026
Aug 06, 2026Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Read With SEBI (PIT) Regulations 2015 Regarding Intimation Of Holding The 2/2026-27 Board Meeting Scheduled To Be Held On Tuesday 11Th Day Of August 2026.Aug 06, 2026
Aug 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2026
Jul 10, 2026Closure of Trading WindowJun 25, 2026
Jun 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 23, 2026
May 23, 2026Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026.May 22, 2026
May 22, 2026Board Meeting Outcome for Regulation 33(3)(D) Of SEBI (LODR) Regulations 2015-Submission Of Standalone & Consolidated Audited Financial Results Along With Audit Report Statement Of Assets And Liabilities And Cash Flow For The Year Ended On 31St March 2026May 22, 2026
May 22, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 18, 2026
May 18, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 18, 2026
May 18, 2026Board Meeting Intimation for Corporate Announcement U/R 29(1)(A) Of SEBI (LODR) Regulations 2015 Regarding Intimation Of Holding Board Meeting For Consideration And Approval Of The Standalone And Consolidated Audited Financial Results As On 31St March 202May 13, 2026
May 13, 2026Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Read With Master SEBI Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 Dated 30Th January 2026.May 04, 2026
May 04, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 07, 2026
Apr 07, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Forwarding Yearly Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011 By The Promoters Along With Their Person Acting In Concert(PAC) Of The Company For The Financial Year Ended On 31St March 2026.Apr 06, 2026
Apr 06, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 03, 2026
Apr 03, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 13, 2026
Feb 13, 2026Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review Report For The Quarter And Nine Months Ended On 31St December 2025Feb 12, 2026
Feb 12, 2026Board Meeting Intimation for Intimation Of Holding 5/2025-26 Board Meeting For Consideration And Approval Of The Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 31St December 2025.Feb 04, 2026
Feb 04, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Jan 08, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 08, 2026
Jan 08, 2026Pursuant To Regulation 30 Read With Schedule III Part A Of SEBI (LODR) Regulations 2015Jan 03, 2026
Jan 03, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Disclosure Under Regulation 30 Of SEBI (LODR) Regulations 2015 Read With Master SEBI Circular SEBI/HO/CFD/Pod2/CIR/P/0155 Dated 11Th November 2024.
Nov 22, 2025
Nov 22, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025
Nov 13, 2025Regulation 33(3) Of SEBI (LODR) Regulations 2015 - Submission Of Standalone & Consolidated Unaudited Financial Results .Nov 12, 2025
Nov 12, 2025Board Meeting Outcome for Regulation 33(3) Of SEBI (LODR) Regulations 2015 Submission Of Standalone & Consolidated Unaudited Financial Results Along With Limited Review ReportNov 12, 2025
Nov 12, 2025Board Meeting Intimation for Board Meeting IntimationNov 07, 2025
Nov 07, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 16, 2025
Oct 16, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationOct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Change in ManagementOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMOct 01, 2025
Oct 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Proceedings Of 37Th Annual General MeetingSep 29, 2025
Sep 29, 2025Closure of Trading WindowSep 23, 2025
Sep 23, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 06, 2025
Sep 06, 2025Business Responsibility and Sustainability Reporting (BRSR)Sep 04, 2025
Sep 04, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.04% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 69.87
ATR(14)
Volatile 0.69
STOCH(9,6)
Neutral 55.31
STOCH RSI(14)
Neutral 67.70
MACD(12,26)
Bullish 0.21
ADX(14)
Strong Trend 35.83
UO(9)
Bearish 41.69
ROC(12)
Uptrend And Accelerating 21.08
WillR(14)
Neutral -24.48
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
